Summary

Dragon Pharma NPP 150 is presented in a 10-milliliter multidose vial, labeled to contain 150 milligrams of nandrolone phenylpropionate per milliliter. To evaluate the product’s potency and ensure its quality, samples of this product were independently procured and funded for analysis by AnabolicLab from a European-based internet source. The samples were acquired between August 1, 2016, and September 15, 2016, and submitted to the internationally accredited SIMEC AG laboratory for thorough testing.

The analysis included HPLC-UV quantitative dosage testing and microbiological contamination assessments (TAMC and TYMC). The results revealed that the product contained 160.4 mg/ml nandrolone phenylpropionate, which exceeds the labeled claim by 6.93%, indicating a significant overdosage. No microbiological contamination was detected.

Testing Results and Authentication

The samples were received by SIMEC AG on September 29, 2016, and the testing report was finalized on November 18, 2016. The product was identified with a lot number of OTU3HG and an expiration date of December 2018.

Product Overview

• Manufacturer: Dragon Pharma
• Product Name: NPP 150
• Active Ingredient: Nandrolone Phenylpropionate
• Lot Number: OTU3HG
• Expiration Date: December 2018
• Delivery Method: Injectable (10-milliliter multidose vial)
• Specification: 150 mg/ml nandrolone phenylpropionate

Sample Acquisition and Testing

• Date Purchased: Between August 1, 2016, and September 15, 2016
• Source: European-based internet supplier
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: September 29, 2016
• Date Report Completed: November 18, 2016

Testing Results

Quantitative Dosage Testing (HPLC-UV):

• Claimed Dosage: 150 mg/ml nandrolone phenylpropionate
• Measured Dosage: 160.4 mg/ml nandrolone phenylpropionate
• Accuracy: 106.93% of the labeled claim
• Variance: +6.93% (measured dosage exceeded the label claim by 6.93%)

Microbiological Contamination Testing:

• TAMC: No contamination detected
• TYMC: No contamination detected

Report Number: #DP-NPP-160404

Conclusion

The analysis of Dragon Pharma NPP 150 determined a measured content of 160.4 mg/ml nandrolone phenylpropionate, representing a 6.93% overdosage relative to the labeled claim. The absence of microbiological contamination further supports the product’s safety profile. However, the significant overdosage raises concerns about consistency in manufacturing processes.

AnabolicLab’s independent testing continues to promote transparency and safety within the anabolic steroid market, empowering consumers to make informed decisions.

Commitment to Harm Reduction

AnabolicLab funds and publishes independent laboratory analyses to support harm reduction practices and enhance transparency in the anabolic steroid market. These efforts aim to ensure consumers have access to reliable, unbiased information about the products they use.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Dragon Pharma NPP 150 lab test results on the AnabolicLab Forum.

(The following images are photographs of the actual product that was submitted for testing.)

Dragon Pharma NPP 150 Dosage Quantification Lab Results [PDF]
How many milligrams of nandrolone phenylpropionate are in each milliliter of Dragon Pharma NPP 150? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (November 18, 2016) …

Size	2.44 MB
Downloaded	838 times
Last Updated	November 19, 2016
Download

---